Cromos Pharma, where the patients are

Europe

Roche, Polyphor partner on multi-drug-resistant bacterial infections

Monday, November 4, 2013 01:39 PM

Roche and Polyphor, a privately-held Swiss pharmaceutical company, have entered into an exclusive worldwide license agreement to develop and commercialize Polyphor’s investigational macrocycle antibiotic, POL7080, for patients suffering from bacterial infections caused by Pseudomonas aeruginosa.

More... »

CRF Health eCOA webinar series

Synexus opens regional center in Poland to support global clinical trials

Wednesday, October 30, 2013 09:05 AM

Synexus has opened a regional office for Eastern Europe in Poland, reflecting the company’s commitment to the region.

More... »


AB-Biotics acquires patent for predicting antipsychotic-induced extrapyramidal symptoms

Tuesday, October 29, 2013 10:00 AM

The Spanish biotech company AB-Biotics has acquired the rights to a patent which predicts the high or low risk of a patient treated with antipsychotic drugs developing extrapyramidal symptoms. Side effects induced by antipsychotic drugs affect patient movement and include muscle rigidity, parkinsonism, akinesia (inability to initiate movement) and akathisia (inability to remain motionless).

More... »

inVentiv Health consolidates U.K. offices

Monday, October 28, 2013 02:23 PM

CRO inVentiv Health has consolidated three Greater London offices into a single, state-of-the-art office space in Berkshire, to better service its European customer base.

More... »

NHS fears changing data protection rules could erode quality of research in U.K.

Friday, October 25, 2013 11:48 AM

The NHS European office and the Royal College of Physicians have warned a new Europe-wide law on data protection could have a negative impact on healthcare provision and erode the quality and effectiveness of health research in the U.K.

More... »

Article: Access to full trial data sets benefits industry

Friday, October 25, 2013 11:46 AM

Access to full data sets from clinical trials will benefit both large and small biopharmaceutical companies and researchers, according to an article published in the New England Journal of Medicine by four members of the EMA staff, including its executive director and senior medical officer. 

More... »

AstraZeneca proposes closing Brixham Environmental Laboratory

Friday, October 25, 2013 11:45 AM

AstraZeneca has announced proposals to close its Environmental Laboratory in Brixham, Devon, U.K. The laboratory, with 71 staff members, provides specialist services to assess the impact of pharmaceuticals and chemicals used by a range of industries on the environment.

More... »

Eight companies receive funding boost in NHS England’s SBRI Healthcare program

Wednesday, October 23, 2013 02:46 PM

SBRI Healthcare, an NHS England funded initiative to develop innovative products and services that address unmet health needs, has awarded eight companies phase I development funding in the latest SBRI competition supporting Mental Health and End of Life Innovations.

More... »

University of Cambridge, Genomics England, Illumina collaborate

Monday, October 21, 2013 01:36 PM

University of Cambridge, Genomics England and Illumina have announced the launch of a three-year project to sequence 10,000 whole genomes of children and adults with rare genetic diseases. The project is a pilot for Genomics England, which will provide 2,000 samples, and marks the beginning of the national endeavor to sequence 100,000 genomes in the U.K. National Health Service (NHS).

More... »

Sanofi, Merck participate in pilot for rapid European health technology assessment

Friday, October 18, 2013 11:06 AM

Sanofi Pasteur MSD is the first vaccine company to have successfully participated in a pilot testing a new rapid relative effectiveness assessment of health technologies in Europe.

More... »

`
CenterWatch Data Library
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

April 14

Proposal calls for back-to-back trials to measure efficacy and effectiveness prior to FDA approval

Study: Minority populations under-represented in cancer trials, but have higher rates of incidence

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

April

Make way for mobile health in clinical trials
Despite patient retention, data quality benefits, regulatory hurdles persist

Global clinical trial laboratories decentralize
Regional labs reducing complexity, delivering cost and time savings

Already a subscriber?
Log in to your digital subscription.

Purchase the April issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

March

Strategic alliances hit bumps in the road
Mixed relationship performance driving new approaches

Tapping community hospitals for clinical trial volunteers
New study finds high potential but infrastructure, resources are lacking

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs